Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2004.031690v1, 2004; 10.1373/clinchem.2004.031690
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2004.031690v1
50/9/1656    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roy, D.
Right arrow Articles by Kaski, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roy, D.
Right arrow Articles by Kaski, J. C.

Received on January 20, 2004
Accepted on June 28, 2004

General Clinical Chemistry

Ischemia-Modified Albumin Concentrations in Patients with Peripheral Vascular Disease and Exercise-Induced Skeletal Muscle Ischemia

Debashis Roy 1, Juan Quiles 1, Rajan Sharma 1, Manas Sinha 1, Pablo Avanzas 1, David Gaze 2, Juan Carlos Kaski 1*

1 Department of Cardiological Sciences St. George's Hospital Medical School, London, UK.
2 Department of Chemical Pathology, St. George's Hospital Medical School, London, UK.

* To whom correspondence should be addressed. E-mail: jkaski{at}sghms.ac.uk.

Background: Ischemia-modified albumin (IMA) is a new marker of myocardial ischemia, there is concern that IMA concentrations may be affected by ischemia occurring in tissues other than the myocardium.

Methods: We assessed 23 consecutive patients (15 males; mean age, 67 years) with typical leg claudication and documented peripheral vascular disease (PVD). All patients underwent both treadmill-exercise stress testing to induce leg ischemia and dobutamine stress echocardiography 1 week apart for the assessment of myocardial ischemia. Blood samples for IMA measurements were obtained at baseline, immediately after peak exercise/stress, and 1 h after exercise/stress. Statistical analysis was performed with the ANOVA repeated-measures test.

Results: Compared with baseline, mean (SD) IMA was significantly lower after the induction of skeletal muscle ischemia and returned to baseline values at 1 h: baseline, 74.6 (15.6) kilounits/L; peak stress, 69.5 (14.0) kilounits/L (P <0.0001 vs baseline); 1 h post stress, 75.9 (15.7) kilounits/L (P <0.0001 vs peak stress; P = 0.3 vs baseline). Baseline, peak stress, and 1-h poststress IMA concentrations were inversely correlated with the ankle-brachial index after exercise (r = -0.4; P <0.05). None of the patients showed regional wall motion abnormalities during dobutamine stress echocardiography, and IMA concentrations remained unchanged from baseline. There were no differences in baseline [74.6 (15.6) vs 72.7 (11.5)kilounits/L; P = 0.6), peak stress, or poststress IMA concentrations when exercise testing and dobutamine stress echocardiography values were compared.

Conclusions: The relationship between disease severity (of a noncardiac origin) and baseline IMA values is an important and novel finding. IMA is significantly lower immediately after exercise-induced leg ischemia in patients with PVD and is related to disease severity. IMA concentrations can therefore be affected by the development of skeletal muscle ischemia, and this may have implications regarding the ability of IMA to detect myocardial ischemia in PVD patients.




The following articles in journals at HighWire Press have cited this article:


Home page
HeartHome page
F Franceschi, J-C Deharo, R Giorgi, Y By, C Monserrat, J Condo, Z Ibrahim, A Saadjian, and R Guieu
Peripheral plasma adenosine release in patients with chronic heart failure
Heart, April 1, 2009; 95(8): 651 - 655.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
P O Collinson and D C Gaze
Ischaemia-modified albumin: clinical utility and pitfalls in measurement
J. Clin. Pathol., September 1, 2008; 61(9): 1025 - 1028.
[Full Text] [PDF]


Home page
Emerg. Med. J.Home page
A Gunduz, A Mentese, S Turedi, S C Karahan, U Mentese, O Eroglu, S Turkmen, I Turan, U Ucar, R Russell, et al.
Serum ischaemia-modified albumin increases in critical lower limb ischaemia
Emerg. Med. J., June 1, 2008; 25(6): 351 - 353.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
S. S. Talwalkar, M. Bon-Homme, J. J. Miller, and R. J. Elin
Ischemia Modified Albumin, a Marker of Acute Ischemic Events: A Pilot Study
Ann. Clin. Lab. Sci., January 1, 2008; 38(2): 132 - 137.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Roy and J. C. Kaski
Ischemia-Modified Albumin: The Importance of Oxidative Stress
J. Am. Coll. Cardiol., June 19, 2007; 49(24): 2375 - 2376.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Sbarouni, P. Georgiadou, G. N. Theodorakis, and D. Th. Kremastinos
Ischemia-Modified Albumin in Relation to Exercise Stress Testing
J. Am. Coll. Cardiol., December 19, 2006; 48(12): 2482 - 2484.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
P. M. van der Zee, H. J. Verberne, J. P. van Straalen, G. T.B. Sanders, B. L.F. Van Eck-Smit, R. J. de Winter, and J. C. Fischer
Ischemia-Modified Albumin Measurements in Symptom-Limited Exercise Myocardial Perfusion Scintigraphy Reflect Serum Albumin Concentrations but Not Myocardial Ischemia
Clin. Chem., September 1, 2005; 51(9): 1744 - 1746.
[Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
J. T. Wu and L. L. Wu
Association of Soluble Markers with Various Stages and Major Events of Atherosclerosis
Ann. Clin. Lab. Sci., January 1, 2005; 35(3): 240 - 250.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 by the American Association for Clinical Chemistry.